Nitrosoureas : current status and new developments

LDR 01207nam a2200325 i 4500
001 002729453
003 MiAaHDL
005 20210817000000.0
006 m d
007 cr bn ---auaua
008 931209s1981 nyua b 100 0 eng
010 ⊔ ⊔ ‡a81000413 //r89
020 ⊔ ⊔ ‡a0125650604
035 ⊔ ⊔ ‡a(MiU)990027294530106381
035 ⊔ ⊔ ‡asdr-miu.990027294530106381
035 ⊔ ⊔ ‡a(OCoLC)7197704
035 ⊔ ⊔ ‡z(MiU)Aleph002729453
040 ⊔ ⊔ ‡aDLC ‡cDLC ‡dm.c. ‡dNLM ‡dEYM
050 0 ⊔ ‡aRC271.N56 ‡bN57
060 ⊔ ⊔ ‡aQZ 267 N731 1980
082 0 ⊔ ‡a616.99/4061 ‡219
245 0 0 ‡aNitrosoureas : ‡bcurrent status and new developments / ‡cedited by Archie W. Prestayko ... [et al.].
260 ⊔ ⊔ ‡aNew York : ‡bAcademic Press, ‡c1981.
300 ⊔ ⊔ ‡axix, 416 p. : ‡bill. ; ‡c24 cm.
504 ⊔ ⊔ ‡aIncludes bibliographies.
538 ⊔ ⊔ ‡aMode of access: Internet.
650 ⊔ 2 ‡aNitrosourea Compounds ‡xAdministration and dosage ‡xCongresses.
650 ⊔ 2 ‡aNitrosourea Compounds ‡xTherapeutic use ‡xCongresses.
650 ⊔ 2 ‡aNeoplasms ‡xDrug therapy ‡xCongresses.
650 ⊔ 2 ‡aDrug Therapy, Combination ‡xCongresses.
650 ⊔ 0 ‡aNitrosoureas ‡xMetabolism ‡xCongresses.
650 ⊔ 0 ‡aNitrosoureas ‡xTesting ‡xCongresses.
650 ⊔ 0 ‡aCancer ‡xChemotherapy ‡xCongresses.
650 ⊔ 0 ‡aNitrosoureas ‡xTherapeutic use ‡xCongresses.
700 1 ⊔ ‡aPrestayko, Archie W.
CID ⊔ ⊔ ‡a002729453
DAT 0 ⊔ ‡a19931209000000.0 ‡b20210817000000.0
DAT 1 ⊔ ‡a20210924060718.0 ‡b2023-07-30T17:38:24Z
CAT ⊔ ⊔ ‡aSDR-MIU ‡dALMA ‡lprepare.pl-004-008
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-miu.990027294530106381 ‡aMiU ‡bSDR ‡cMIU ‡pmdp.39015028907759 ‡sMIU ‡1990027294530106381
974 ⊔ ⊔ ‡bMIU ‡cMIU ‡d20230730 ‡sgoogle ‡umdp.39015028907759 ‡y1981 ‡ric ‡qbib ‡tUS bib date1 >= 1929